| Issue |
Title |
File |
| Vol 13, No 4 (2018) |
Clinical and biological features of acute myeloid leukemia with MLL gene rearrangements in children and results of therapy according to protocols AML-MM-2000/2006 in the Republic of Belarus |
(Rus)
|
|
Barovskaya Y.A., Stegantseva M.V., Aleinikova O.V.
|
| Vol 13, No 4 (2018) |
Efficacy and safety of nivolumab in the treatment of relapsed/refractory classical Hodgkin’s lymphoma: Pavlov First Saint Petersburg State Medical University experience |
(Rus)
|
|
Lepik K.V., Mikhailova N.V., Kondakova E.V., Tsvetkova L.A., Zalyalov Y.R., Borzenkova E.S., Moiseev I.S., Baykov V.V., Afanasyev B.A.
|
| Vol 13, No 4 (2018) |
CD-19-directed immunotherapy resistance mechanisms of B-precursor acute lymphoblastic leukemia |
(Rus)
|
|
Glukhanyuk E.V., Stepanov A.V., Popov A.M., Maschan M.A.
|
| Vol 13, No 4 (2018) |
Blood coagulation in venous thrombosis, complicating treatment of children, adolescents and young adults with lymphomas |
(Rus)
|
|
Dmitriev V.V., Fedorova A.S., Lipay N.V., Begun I.V., Dunaev I.A., Dmitriev E.V.
|
| Vol 13, No 4 (2018) |
Bone marrow MRI after autologous transplantation and the effect of residual tumor on progression-free survival of multiple myeloma patients |
(Rus)
|
|
Solovev M.V., Mendeleeva L.P., Yatsyk G.A., Lutsik N.S., Firsova M.V., Gemdzhian E.G., Savchenko V.G.
|
| Vol 13, No 4 (2018) |
Brentuximab vedotin (Adcetris®) in therapy of system anaplastic large cell lymphoma. Case report |
(Rus)
|
|
Semenova A.A., Zeynalova P.A., Nikitina M.S., Akhmedov M.I.
|
| Vol 13, No 4 (2018) |
Impact of malignant neoplasms on musculoskeletal system in children (literature review) |
(Rus)
|
|
Tikhonova O.A., Krutikova N.Y., Karelin A.F., Zhukovskaya E.V., Rumyantsev A.G.
|
| Vol 13, No 3 (2018) |
Follicular lymphoma: results of multicenter study of first-line therapy with bendamustine and rituximab, risk factors for adverse events (fl-rus-2013 protocol) |
(Rus)
|
|
Nesterova E.S., Kravchenko S.K., Kovrigina A.M., Gemdzhian E.G., Plastinina L.V., Mangasarova Y.K., Babaeva F.E., Misyurina A.E., Margolin O.V., Magomedova A.U., Vorobiev V.I., Maryin D.S., Baryakh E.A., Polyakov Y.Y., Zeynalova P.A., Volodicheva E.M., Glonina N.N., Minaeva N.V., Davydova G.A., Savchenko V.G.
|
| Vol 13, No 3 (2018) |
Cutaneous T-cell lymphomas: modern data of pathogenesis, clinics and therapy |
(Rus)
|
|
Demina O.M., Akilov O.E., Rumyantsev A.G.
|
| Vol 13, No 3 (2018) |
Modern concepts of the mycosis fungoides pathogenesis |
(Rus)
|
|
Vorontsova A.A., Karamova A.E., Znamenskaya L.F.
|
| Vol 13, No 3 (2018) |
Approaches to the prevention and therapy of ibrutinib-associated bleeding in adult patients |
(Rus)
|
|
Volchkov E.V., Zharkov P.A., Panteleev M.A.
|
| Vol 13, No 2 (2018) |
VENOUS THROMBOSIS IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH LYMPHOMAS: INCIDENCE, CHARACTERISTICS, RISK FACTORS AND PROGNOSTIC VALUE |
(Rus)
|
|
Fedorova A.S., Dmitriev V.V., Lipay N.V., Markоvets A.F., Begun I.V., Dmitriev E.V.
|
| Vol 13, No 2 (2018) |
CLINICAL CHARACTERISTICS AND TREATMENT RESULTS OF PEDIATRIC RELAPSED/REFRACTORY NON-HODGKIN’S LYMPHOMAS |
(Rus)
|
|
Valiev T.T.
|
| Vol 13, No 2 (2018) |
VENETOCLAX IN TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (literature review) |
(Rus)
|
|
Byalik T.E.
|
| Vol 13, No 2 (2018) |
INVASIVE ASPERGILLOSIS AND MUCORMYCOSIS IN ONCOHEMATOLOGICAL PATIENTS |
(Rus)
|
|
Shadrivova O.V., Khostelidi S.N., Chudinovskikh Y.A., Zabirov V.S., Borzova Y.V., Desyatik E.A., Volkova A.G., Popova M.O., Markova I.V., Uspenskaya O.S., Ruzhinskaya O.S., Shneyder T.V., Bogomolova T.S., Ignatyeva S.M., Zubarovskaya L.S., Afanasyev B.V., Klimko N.N.
|
| Vol 13, No 2 (2018) |
RATIONAL SUPPORTIVE THERAPY FOR CHEMOTHERAPY INDUCED ANEMIA: A PHARMACO-ECONOMIC ANALYSIS OF ERYTHROPOIETIN THERAPY IN CANCER PATIENTS IN RUSSIAN FEDERATION |
(Rus)
|
|
Larionova V.B., Krysanov I.S., Snegovoy A.V., Zeinalova P.A., Krysanova V.S., Ermakova V.Y.
|
| Vol 13, No 2 (2018) |
REFRACTORINESS TO DONOR PLATELETS TRANSFUSION IN PATIENTS WITH APLASTIC ANEMIA AND HEMOBLASTOSIS |
(Rus)
|
|
Rakhmani A.F., Mikhaylova E.A., Dubinkin I.V., Kalmikova O.S., Galuzyak V.S., Troitskaya V.V., Gaponova T.V.
|
| Vol 13, No 2 (2018) |
MORPHOLOGICAL FEATURES OF TUMORS SUBSTRATE IN MULTIPLE MYELOMA PATIENTS COMPLICATED WITH PLASMACYTOMA |
(Rus)
|
|
Firsova M.V., Mendeleeva L.P., Kovrigina A.M., Deyneko N.I., Soloviev M.V., Gemdzhyan E.G., Savchenko V.G.
|
| Vol 13, No 1 (2018) |
THE EFFICACY OF HIGH-DOSE CONSOLIDATION AND AUTOLOGOUS BONE MARROW TRANSPLANTATION IN FIRST REMISSION OF ACUTE MYELOID LEUKEMIA |
(Rus)
|
|
Samorodova I.A., Bondarenko S.N., Ovechkina V.N., Klimovich A.V., Podolceva E.I., Medvedeva N.V., Nizamutdinova A.S., Karyagina E.V., Smirnov B.I., Moiseev I.S., Zubarovskaya L.S., Afanasyev B.V.
|
| Vol 13, No 1 (2018) |
EXTRAMEDIASTINAL LESION IN PATIENTS WITH PRIMARY MEDIASTINAL B-CELL LYMPHOMA |
(Rus)
|
|
Mangasarova Y.K., Magomedova A.U., Kovrigina A.M., Kostina I.E., Nesterova E.S., Gorenkova L.G., Misyurina A.E., Margolin O.V., Kravchenko S.K.
|
| Vol 13, No 1 (2018) |
NEW APPROACHES TO THERAPY OF CLASSICAL PH-NEGATIVE MYELOPROLIFERATIVE DISEASES: THE EXPERIENCE OF EARLY THERAPY WITH CEPEGINTERFERON ALPHA-2B |
(Rus)
|
|
Polyakov A.S., Noskov Y.A., Tyrenko V.V., Lapshova A.S., Kovalev A.V.
|
| Vol 13, No 1 (2018) |
ANEMIA OF CHRONIC DISEASE: FEATURES OF PATHOGENESIS AND POSSIBLE THERAPEUTIC CORRECTION (LITERATURE REVIEW AND RESULTS OF OWN RESEARCH) |
(Rus)
|
|
Sakhin V.Т., Madzhanova Е.R., Kryukov E.V., Kazakov S.P., Rukavitsin O.A.
|
| Vol 12, No 4 (2017) |
COMBINATION OF INVASIVE ASPERGILLOSIS AND MUCORMYCOSIS IN ONCOHEMATOLOGICAL PATIENTS |
(Rus)
|
|
Shadrivova O.V., Khostelidi S.N., Borzova Y.V., Desyatik E.A., Volkova A.G., Popova M.O., Uspenskaya O.S., Ruzhinskaya O.S., Shneyder T.V., Bogomolova T.S., Ignatyeva S.M., Zubarovskaya L.S., Afanasyev B.V., Klimko N.N.
|
| Vol 12, No 4 (2017) |
EFFECTIVENESS OF VENETOСLAX IN THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (LITERATURE REVIEW) |
(Rus)
|
|
Strugov V.V., Stadnik E.A., Zaritskey A.Y.
|
| Vol 12, No 4 (2017) |
REACTIVE PLASMACYTOSIS AT THE ONSET OF ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA. CASE REPORT |
(Rus)
|
|
Chernova N.G., Sinitsyna M.N., Kovrigina A.M., Sidorova Y.V., Galtseva I.V., Mar’ina S.A., Dvirnyk V.N., Zvonkov E.E.
|
| Vol 12, No 3 (2017) |
TOXICITY AND EFFICACY OF TYROSINE KINASE INHIBITORS IN COMBINATION WITH CHEMOTHERAPY IN PATIENT WITH RESISTANT Ph-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (CASE REPORT AND LITERATURE REVIEW) |
(Rus)
|
|
Zarubina K.I., Parovichnikova E.N., Gavrilina O.A., Sokolov A.N., Troitskaya V.V., Kuzmina L.A., Mamonov V.E., Galstyan G.M., Savchenko V.G.
|
| Vol 12, No 3 (2017) |
EPIDEMIOLOGY OF MULTIPLE MYELOMA ACCORDING TO THE КIROV REGION POPULATION REGISTERS |
(Rus)
|
|
Luchinin A.S., Semochkin S.V., Minaeva N.V., Pozdeev N.M., Paramonov I.V.
|
| Vol 12, No 3 (2017) |
CLINICAL AND LABORATORY FEATURES OF ESSENTIAL THROMBOCYTOSIS AND PRIMARY MYELOFIBROSIS DEPENDING ON JAK2 AND CALR1 MUTATION STATUS |
(Rus)
|
|
lisina E.G., Siordiya N.T., Butylin P.A., Silyutina A.A., Matyukhina N.M., Senderova O.M., Fokina E.S., Ovsepyan V.A., Lomaia E.G., Zaritskiy A.Y.
|
| Vol 12, No 3 (2017) |
CDKN2A/p16INK4a DELETION IS NOT A POOR PROGNOSTIC FACTOR IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS TREATED ACCORDING TO PROTOCOL RALL-2009 |
(Rus)
|
|
Piskunova I.S., Obukhova T.N., Parovichnikova E.N., Kulikov S.M., Gavrilina O.A., Lukyanova I.A., Savchenko V.G.
|
| Vol 12, No 3 (2017) |
RISK FACTORS AND INCIDENCE OF MYOCARDIAL DAMAGE IN PATIENTS WITH HEMOBLASTOSIS RECEIVING ANTHRACYCLIN ANTIBIOTICS |
(Rus)
|
|
Vatutin N.T., Sklyannaya E.V., El-Khatib M.A., Sologub I.A.
|
| Vol 12, No 3 (2017) |
INFECTIONS ON DIFFERENT CHEMOTHERAPY CYCLES IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH ALL-2009 PROTOCOL |
(Rus)
|
|
Okhmat V.A., Klyasova G.A., Parovichnikova E.N., Troitskaya V.V., Gribanova E.O., Malchikova A.O., Korobova A.G., Frolova I.N., Savchenko V.G.
|
| Vol 12, No 2 (2017) |
TREATMENT OF RELAPSE AND REFRACTORY HODGKIN LYMPHOMA |
(Rus)
|
|
Baryakh E.A.
|
| Vol 12, No 2 (2017) |
MUCORMYCOSIS IN ONCOHEMATOLOGY PATIENTS (results of the prospective study) |
(Rus)
|
|
Klimko N.N., Khostelidi S.N., Shadrivova O.V., Bogomolova T.S., Avdeenko Y.L., Volkova A.G., Popova M.O., Mihailova I.A., Kolbin A.S., Boychenko E.G., Medvedeva N.V., Podoltseva E.I., Klimovich A.V., Belogurova M.B., Zuzgin I.S., Uspenskaya O.S., Semelev V.N., Ponomoreva N.I., Abdilova G.K., Zuborovskaya L.S., Afanasiev B.V.
|
| Vol 12, No 2 (2017) |
SUCCESSFUL USE OF BRENTUXIMAB VEDOTIN IN THE TREATMENT OF PROGRESSIVE PERIPHERAL UNSPECIFIED T-CELL LYMPHOMA IN AN ELDERLY FEMALE PATIENT |
(Rus)
|
|
Gorenkova L.G., Kravchenko S.K., Klebanova E.E., Danishyan K.I., Silaev M.A., Kovrigina A.M., Rizikova N.V., Skidan N.I., Ceitlina M.A., Savchenko V.G.
|
| Vol 12, No 2 (2017) |
THROMBOTIC AND BLEEDING RISK FACTORS IN ESSENTIAL THROMBOCYTHEMIA |
(Rus)
|
|
Zhernyakova A.A., Martynkevich I.S., Shuvaev V.A., Polushkina L.B., Fominykh M.S., Udal’eva V.Y., Zotova I.I., Shiсhbabaeva D.I., Voloshin S.V., Бессмельцев S.S., Chechetkin A.V., Abdulkadyrov K.M.
|
| Vol 12, No 1 (2017) |
Primary diffuse large B-cell lymphoma of the central nervous system (case report and literature review) |
(Rus)
|
|
Komratova K.A., Abugova Y.G., Ozerov S.S., Abramov D.S., Tereshchenko G.V., Myakova N.V.
|
| Vol 12, No 1 (2017) |
Adoptitive immunotherapy with genetically engineered T lymphocytes modified to express chimeric antigen receptors |
(Rus)
|
|
Pavlova A.А., Maschan M.А., Ponomarev V.B.
|
| Vol 12, No 1 (2017) |
How to use ibrutinib |
(Rus)
|
|
Nikitin Е.А., Vorobiev V.I., Panteleev М.А., Gendlin G.E., Ptushkin V.V.
|
| Vol 12, No 1 (2017) |
Clinical, laboratory, and morphological characteristics of kidney damage in lymphoproliferative disorders |
(Rus)
|
|
Dzhumabaeva B.T., Biryukova L.S., Varshavsky V.A., Mar’ina S.A., Roshchina L.S., Julhakyan U.L., Stolyarevich E.S.
|
| Vol 11, No 4 (2016) |
MYELODYSPLASTIC/MYELOPROLIFERATIVE DISEASES |
(Rus)
|
|
Subortseva I.N., Melikyan A.I.
|
| Vol 11, No 4 (2016) |
PROGNOSTIC SIGNIFICANCE OF POSITRON EMISSION TOMOGRAPHY IN AUTOLOGOUS STEM CELL TRANSPLANTATION FOR NON-HODGKIN’S LYMPHOMA |
(Rus)
|
|
Potapenko V.G., Mikhaylova N.B., Smirnov B.I., Skorokhod I.A., Chaginskaya D.A., Ryabchikova V.V., Samorodova I.А., Podol’tseva E.I., Ipatov V.V., Boykov I.V., Semelev V.N., Gornostaev D.A., Potapenko T.G., Kulibaba T.G., Medvedeva N.V., Afanas’ev B.V.
|
| Vol 11, No 4 (2016) |
MOLECULAR BIOLOGICAL CHARACTERISTICS OF ALK-POSITIVE ANAPLASTIC LARGE CELL LYMPHOMA |
(Rus)
(Eng)
|
|
Chernyshova E.V., Abramov D.S., Konovalov D.M., Larin S.S., Myakova N.V.
|
| Vol 11, No 4 (2016) |
IKZF1 DELETIONS ARE INDEPENDENT PROGNOSTIC FACTOR IN PEDIATRIC B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA |
(Rus)
|
|
Tsaur G.A., Druy A.Е., Solodonikov A.G., Popov A.M., Shapochnik A.P., Vakhonina L.V., Vlasova А.А., Riger Т.О., Verzhbitskaya T.Y., Olshanskaya Y.V., Shorikov E.V., Arakaev О.R., Saveliev L.I., Fechina L.G.
|
| Vol 11, No 3 (2016) |
Treatment patterns, outcomes and long-term toxicity among patients with Hodgkin’s lymphoma in real world: results of a hospital based registry |
(Rus)
|
|
Nikitin E.A., Sharkunov N.N., Markaryan V.G., Lobanova N.A., Ptushkin V.V.
|
| Vol 11, No 3 (2016) |
Risks of postmetachronous malignancies in patients with Hodgkin lymphoma after radio- and chemotherapy |
(Rus)
|
|
Danilenko A.A., Shakhtarina S.V., Pavlov V.V.
|
| Vol 11, No 3 (2016) |
Extranodal NK/T-cell lymphoma: a review of literature and case report |
(Rus)
|
|
Chernova N.G., Nareyko M.V., Sinitsyna M.N., Sidorova Y.V., Yatsy G.A., Kovrigina A.M., Zvonkov E.E., Dvirnyk V.N., Kuz’mina L.A., Parovichnikova E.N., Savchenko V.G.
|
| Vol 11, No 3 (2016) |
Comparison of diagnostic effectiveness of X-ray computed tomography, magnetic resonance imaging and diffusion-weighted magnetic resonance imaging in the differentiation of residual tumors and posttherapeutic masses in patients with lymphoma after treatment |
(Rus)
|
|
Khoruzhik S.A., Zhavrid E.A., Sachivko N.V.
|
| Vol 11, No 3 (2016) |
Should to all patients with febrile neutropenia and colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae carbapenems be appointed? |
(Rus)
|
|
Okhmat V.A., Klyasova G.A., Korobova A.G., Parovichnikova E.N., Fedorova A.V., Troitskaya V.V., Gribanova E.O., Savchenko V.G.
|
| Vol 11, No 3 (2016) |
Clinical and microbiological characteristics of bloodstream infections in hematological cancer patients |
(Rus)
|
|
Chebotkevich V.N., Bessmel’tsev S.S., Kiseleva E.E., Stizhak N.P., Kaytandzhan E.I., Burylev V.V.
|
| Vol 11, No 3 (2016) |
Results of external quality control study in flow cytometric acute lymphoblastic leukemia diagnostics |
(Rus)
|
|
Popov A.M., Verzhbitskaya T.U., Zueva E.E., Anan’eva O.V., Babenko E.V., Baydun L.V., Belyakova E.A., Boyakova E.V., Bortnikova O.G., Gorchakova M.V., Grivtsova L.Y., Grinkevich E.N., Davydova Y.V., Zakhar’ko E.I., Illarionova O.I., Kaprano N.M., Koroleva E.A., Kochengina S.A., Kuz’mina E.G., Kustova E.A., Makarova T.A., Mirolyubova Y.V., Murashkina O.E., Mushkarina T.Y., Nisheva E.S., Novikova I.A., Osipova E.Y., Pluzhnikova G.E., Pochtar M.E., Pronkina N.V., Rusanova E.V., Rybkina E.B., Seliverstova O.V., Tupitsin N.N., Uleyskaya G.I., Urazalieva N.T., Fechina L.G., Khoroshikh O.V., Tsareva O.E., Shchekina L.A., Plyasunova S.A., Lugovskaya S.A.
|
| Vol 11, No 2 (2016) |
Molecular cytogenetic follow-up of chronic lymphocytic leukemia patients with unfavorable prognosis |
(Rus)
|
|
Shkavrova T.G., Mikhailova G.F., Goloub E.V., Tsepenko V.V., Danilenko A.A., Pavlov V.V.
|
| Vol 11, No 2 (2016) |
Combination therapy with ruxolitinib plus low-dose cytarabine or mercaptopurine in patients with blast-phase myelofibrosis |
(Rus)
|
|
Fominykh M.S., Shuvaev V.A., Martynkevich I.S., Polushkina L.B., Udal’eva V.Y., Abdulkadyrov K.M.
|
| Vol 11, No 2 (2016) |
Castleman disease (literature review) |
(Rus)
|
|
Melikyan A.L., Egorova E.K.
|
| Vol 11, No 2 (2016) |
Lineage switch in relapse of acute leukemia with rearrangement of MLL gene (KMT2A). literature review and case reports |
(Rus)
|
|
Zerkalenkova E.A., Illarionova O.I., Kazakova A.N., Ponomareva N.I., Baydun L.V., Osipova E.Y., Dubrovina M.E., Popov A.M., Konyukhova T.V., Plyasunova S.A., Myakova N.V., Maschan A.A., Olshanskaya Y.V.
|
| Vol 11, No 1 (2016) |
Brentuximab vedotin in children and adolescents with Hodgkin’s lymphoma and anaplastic large cell lymphoma – literature review and own experience |
(Rus)
|
|
Myakova N.V., Evstratov D.A., Abramov D.S., Konovalov D.M., Pshonkin A.V., Litvinov D.V.
|
| Vol 11, No 1 (2016) |
Genetic heterogeneity of infant acute leukemias |
(Rus)
|
|
Tsaur G.A., Fleischman E.W., Popov A.M., Fechina L.G., Rumyantsev S.A.
|
| Vol 11, No 1 (2016) |
Dasatinib: ten years of clinical practice worldwide |
(Rus)
|
|
Abdulkadyrov K.M., Shuvaev V.A., Martynkevich I.S.
|
| Vol 11, No 1 (2016) |
BRAF and MAP2K1 mutations in hairy cell leukemia and splenic marginal zone B-cell lymphoma |
(Rus)
|
|
Yakutik I.A., Al’-Radi L.S., Julhakyan H.L., Biderman B.V., Sudarikov A.B.
|
| Vol 11, No 1 (2016) |
Anemia of chronic diseases: the important aspects of pathogenesis and treatment |
(Rus)
|
|
Rukavitsyn O.A.
|
| Vol 10, No 4 (2015) |
Efficacy of lenalidomide, bortezomib, and prednisolone in patients with relapsed or refractory multiple myeloma |
(Rus)
|
|
Мitinа T.A., Golenkov A.K., Trifonova E.V., Kataeva E.V., Vysotskaya L.L., Chernykh Y.B., Zakharov S.G., Belousov K.A., Karaulov A.V.
|
| Vol 10, No 4 (2015) |
Treatment of B-cells non-Hodgkin lymphomas with combined immunochemotherapy: ability to treatment optimization |
(Rus)
|
|
Smirnova N.V., Myakova N.V., Belogurova M.B., Ryskal O.V., Nikonova O.E., Sharapova G.R., Fedorova A.S., Grigorieva N.A., Shamardina A.V., Ponomareva N.I., Abramov D.S., Konovalov D.M., Dubrovina M.E., Maschan A.A., Samochatova E.V.
|
| Vol 10, No 4 (2015) |
Glomerulonephritis associated with marginal zone B-cell lymphoma: clinical, pathological characteristics of renal injury and treatment (clinical cases) |
(Rus)
|
|
Dzhumabaeva B.T., Birukova L.S., Golitsyna E.P., Varshavskiy V.A., Julhakyan U.L., Roshchina L.S.
|
| Vol 10, No 4 (2015) |
Splenic B-cell marginal zone lymphoma with marked plasmocytic differentiation: tumor variant from Mott cells? |
(Rus)
|
|
Julhakyan U.L., Dvirnyk V.N., Mendeleeva L.P.
|
| Vol 10, No 4 (2015) |
Lipegfilgrastim in patients with chemotherapy-induced neutropenia |
(Rus)
|
|
Petrova G.D., Chernyavskaya T.Z., Gorbunova N.V., Kostrykina V.N., Doronin V.A., Melkova K.N.
|
| Vol 10, No 3 (2015) |
The multicenter experience with bendamustine in the treatment of relapsed and refractory multiple myeloma |
(Rus)
|
|
Voloshin S.V., Bessmeltsev S.S., Zagoskina T.P., Medvedeva N.V., Kaplanov K.D., Karyagina E.V., Garifullin A.D., Kuvshinov A.Y., Stelmashenko L.V., Abdulkadyrov K.M.
|
| Vol 10, No 3 (2015) |
Quality of life, symptom profile and clinical efficacy of second-line treatment with dasatinib in patients with imatinib-resistant or -intolerant chronic myeloid leukemia: results of 2-year follow-up |
(Rus)
|
|
Ionova T.I., Nikitina T.P., Lomaia E.G., Kuchma G.B., Machyulaytene E.R., Usacheva E.I., Shnaider T.V., Rodionova A.Y., Kurbatova K.A.
|
| Vol 10, No 3 (2015) |
All we know about polycythemia vera: literature review and own experience |
(Rus)
|
|
Abdulkadyrov K.M., Shuvaev V.A., Martynkevich I.S.
|
| Vol 10, No 3 (2015) |
Pomalidomide for the management of relapsed and refractory multiple myeloma: a case report and review of literature |
(Rus)
|
|
Semochkin S.V.
|
| Vol 10, No 3 (2015) |
In vitro anidulafungin activity against yeasts – system and disseminated mycosis pathogens |
(Rus)
|
|
Kulko A.B.
|
| Vol 10, No 3 (2015) |
Cardiovascular and metabolic problems associated with application of second generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia |
(Rus)
|
|
Vinogradova O.Y.
|
| Vol 10, No 2 (2015) |
Combination of arsenicum trioxide and all trans retinoic acid in the treatment of relapsed acute promyelocytic leukemia |
(Rus)
|
|
Sokolov A.N., Parovichnikova E.N., Troitskaya V.V., Kuzmina L.A., Savchenko V.G.
|
| Vol 10, No 2 (2015) |
Clinical and economic analysis of voriconazole using for treatment of invasive aspergillosis in Russian Federation |
(Rus)
|
|
Ignatieva V.I., Avksentieva M.V.
|
| Vol 10, No 2 (2015) |
Primary myelofibrosis: own experience and news from diagnostic and treatment |
(Rus)
|
|
Abdulkadyrov K.M., Shuvaev V.A., Martynkevich I.S.
|
| Vol 10, No 2 (2015) |
Prevention of neutropenia during chemotherapy by prolonged myelostimulatory preparations |
(Rus)
|
|
Ptushkin V.V., Zhukov N.V., Borisov V.I., Minenko S.V., Larina Y.V.
|
| Vol 10, No 2 (2015) |
Labaratory capacity of differential anemia diagnosis |
(Rus)
|
|
Meshсheryakova L.M., Levina A.A., Tsybulskaya M.M., Sokolova T.V.
|
| Vol 10, No 1 (2015) |
Initial renal function and type of chemotherapy: impact on treatment efficacy in patients with chronic lymphocytic leukemia |
(Rus)
|
|
Nikitina A.K., Saraeva N.O.
|
| Vol 10, No 1 (2015) |
Strategy of medical, psychological and social rehabilitation for children with haematological and oncological diseases |
(Rus)
|
|
Volodin N.N., Kasatkin V.N., Tseitlin G.Y., Sidorenko L.V., Mironova E.V., Mitrakov N.N., Miroshkin R.B., Shcheglova D.D., Rumyantsev A.G.
|
| Vol 10, No 1 (2015) |
Combination of bendamustine and rituximab in the management of relapsed and refractory chronic lymphocytic leukemia: the results of retrospective study |
(Rus)
|
|
Semochkin S.V., Arshanskaya E.G., Zakharov O.D., Kotelnikova A.N., Kulikova S.S., Ovanesova E.V., Kochkareva Y.B., Ivanova V.L.
|
| Vol 9, No 4 (2014) |
Clinical and microbiological characteristics of bacteremia caused by Streptococcus viridans in children with hematologic malignancies |
(Rus)
|
|
Panina M.V., Klyasova G.A., Novichkova G.A., Myakova N.V., Litvinov D.V., Baydildina D.D., Maschan M.A., Maschan A.A.
|
| Vol 9, No 4 (2014) |
Chronic lymphoproliferative diseases: survival in cohort study of 310 patients (single-center study results and literature data) |
(Rus)
|
|
Pop V.P., Rukavitsyn O.A.
|
| Vol 9, No 3 (2014) |
Interim results of the Ph-negative acute lymphoblastic leukemia treatment in adult patients (results of Russian research group of ALL treatment (RALL)) |
(Rus)
|
|
Parovichnikova E.N., Troitskaya V.V., Sokolov A.N., Akhmerzaeva Z.K., Kuzmina L.A., Mendeleeva L.P., Klyasova G.A., Kravchenko S.K., Gribanova Y.O., Bondarenko S.N., Baranova O.Y., Kaporskaya T.S., Ryltsova T.V., Nizamutdinova A.S., Zagoskina T.P., Zinina Y.Y., Samoylova O.S., Klimovich A.V., Karyakina Y.A., Yelufer’eva A.S., Gavrilova L.V., Konstantinova T.S., Toropova I.Y., Pristupa A.S., Vopilina N.A., Tikunova T.S., Skamorina O.P., Kaplanov K.D., Obukhova T.N., Galtseva I.V., Rusinov M.A., Kulikov S.M., Savchenko V.G.
|
| Vol 9, No 3 (2014) |
Pharmacoeconomic modeling of target therapy of chronic myeloid leukemia in remission |
(Rus)
|
|
Shuvaev V.A., Abdulkadyrov K.M., Martynkevich I.S., Fominykh M.S.
|
| Vol 9, No 2 (2014) |
Health of children born to women after radiation and chemotherapy for Hodgkin's lymphoma |
(Rus)
|
|
Danilenko A.A., Shakhtarina S.V., Shchelkonogova L.N., Pavlov V.V.
|
| Vol 9, No 2 (2014) |
Invasive aspergillosis: results of multicenter study |
(Rus)
|
|
Klimko N.N., Shadrivova O.V., Khostelidi S.N., Desyatik E.A., Borzova Y.V., Chernopyatova R.M., Shagdileeva E.V., Volkova A.G., Popova M.O., Zyuzgin I.S., Ruzhinskaya O.S., Ryabykina O.Y., Medvedeva N.V., Kolbin A.S., Boychenko E.G., Bogomolova T.S., Ignatieva S.M., Zubarovskaya L.S., Afanasiev B.V.
|
| Vol 9, No 2 (2014) |
National clinical guidelines for the diagnosis and treatment of paroxysmal nocturnal hemoglobinuria |
(Rus)
|
|
Kulagin A.D., Lisukov I.A., Ptushkin V.V., Shilova Y.R., Tsvetaeva N.V., Mikhailova Y.A.
|
| Vol 9, No 1 (2014) |
Therapy efficacy in multiple myeloma patients received autologous stem cells transplantation as first line therapy |
(Rus)
|
|
Darskaya Y.I., Marami-Zonuzi N.E., Osipov Y.S., Estrina M.A., Babenko Y.V., Vavilov V.N., Afanasiev B.V.
|
| Vol 9, No 1 (2014) |
Treatment of advanced Hodgkin lymphomas in adolescents and young adults: efficacy and toxicity issues |
(Rus)
|
|
Larina Y.V., Minenko S.V., Biyachuev E.R., Pshonkin A.V., Khuazheva N.K., Ptushkin V.V.
|
| Vol 8, No 4 (2013) |
Tyrosine kinase inhibitors therapy related neutropenia and thrombocythopenia correction in CML patients |
(Rus)
|
|
Shuvaev V.A., Fominykh M.S., Martynkevich I.S., Udaleva V.Y., Potikhonova N.A., Zenina M.N., Abdulkadyrov K.M.
|
| Vol 8, No 4 (2013) |
Frequency of red cell, leukocytic and platelet alloantibodies in patients with hematological diseases |
(Rus)
|
|
Mineeva N.V., Gavrovskaya S.V., Krobinets I.I., Pashkova I.A., Bodrova N.N., Sysoeva E.A.
|
| Vol 8, No 4 (2013) |
Own experience of primary mediastinal B-large cell lymphoma treatment |
(Rus)
|
|
Vernyuk M.A., Tyurina N.G., Pavlova O.A., Chervontseva A.M., Zhukov N.V.
|
| Vol 8, No 4 (2013) |
Neuromuscular disorders in acute leukemia and lymphoma treatment |
(Rus)
|
|
Politova E.A., Zavadenko N.N., .
|
| Vol 8, No 4 (2013) |
Anesthetic management of minimally invasive intervention in pediatric oncohematology: possibilities and limitations of inhalation and intravenous anesthesia |
(Rus)
|
|
Shchukin V.V., Kharkin A.V., Spiridonova E.A., Lazarev V.V., Tsypin L.E., Aizenberg V.L.
|
| Vol 8, No 3 (2013) |
Development of oncology: from despair to hope... |
(Rus)
|
|
Zhukov N.V., Rumyantsev A.G.
|
| Vol 8, No 3 (2013) |
The comparative analysis of BCR-ABL/ABL detection by real-time quantitative PCR and automated GeneXpert Dx System in chronic myeloid leukemia patients with major and complete molecular response |
(Rus)
|
|
Smirnikhina S.A., Tsaur G.A., Chelysheva E.Y., Yakovleva Y.A., Lavrov A.V., Аbdullaev A.O., Bederak N.V., Shukhov O.A., Solodovnikov A.G., Popov A.M., Adilgereeva E.P., Fechina L.G., Turkina A.G., Kutsev S.I.
|
| Vol 8, No 3 (2013) |
Anesthetic management of minimally invasive intervention in children's oncohematology: preoperative patient management protocol |
(Rus)
|
|
Shchukin V.V., Spiridonova E.A., Lazarev V.V., Khar'kin A.V., Tsypin L.E., Ayzenberg V.L.
|
| Vol 8, No 2 (2013) |
Contemporary conceptions of etiology, pathogenesis, management and treatment of primary diffuse large b-cell central nervous system lymphoma |
(Rus)
|
|
Voloshin S.V., Krivolapov Y.A., Shmidt A.V., Shuvaev V.A., Fominykh M.S., Abdulkadyrov K.M.
|
| Vol 8, No 2 (2013) |
Efficacy and safety of tyrosine kinase inhibitors (dasatinib, nilotinib) in the treatment of chronic phase chronic myeloid leukemia |
(Rus)
|
|
Lomaia E.G., Romanova E.G., Sbityakova E.I., Zaritskiy A.Y.
|
| Vol 8, No 2 (2013) |
Subcutaneous panniculitis-like T-cell lymphoma in children. Literature review and case reports |
(Rus)
|
|
Abramov D.S., Konovalov D.M., Rogozhin D.V., Myakova N.V., Biyachuev E.R., Roshchin V.Y., Mitrofanova A.M., Kislyakov A.N.
|
| Vol 8, No 2 (2013) |
Thrombotic complications in children with non-Hodgkin lymphoma |
(Rus)
|
|
Lipay N.V., Fedorova A.S., Dmitriev V.V.
|
| Vol 8, No 1 (2013) |
Chronic myelogenous leukemia: molecular monitoring in clinical practice |
(Rus)
|
|
Ryabchikova N.R., Minniakhmetov I.R., Safuanova G.S., Islamgulov D.V., Karunas A.S., Khusnutdinova E.E.
|
| 1 - 100 of 158 Items |
1 2 > >>
|
